NCT02205905View on ClinicalTrials.gov

An Open-label, Single-dose, Non-randomized Study of IV 14C-labeled PER977 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Healthy
Interventions
DRUG

14C PER977

Open-label, single dose

Trial Locations (1)

78217

Worldwide Clinical Trials Early Phase Services, San Antonio

All Listed Sponsors
collaborator

World Wide Clinical Trials Early Phase Services, LLC

UNKNOWN

lead

Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.

INDUSTRY

NCT02205905 - An Open-label, Single-dose, Non-randomized Study of IV 14C-labeled PER977 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter